BACKGROUND/AIMS: The canonical Wnt signaling is frequently activated in human hepatocellular carcinoma (HCC). We previously demonstrated that upregulation of Frizzled-7 receptor (FZD7) in HCC was associated with nuclear accumulation of wild-type beta-catenin. Here, we investigated Wnt ligand(s) that may activate the Wnt/beta-catenin pathway through FZD7 in HCC cells. METHODS: To identify Wnt ligand expression, RT-PCR was performed in HCC cells. To evaluate the function of Wnt3 and FZD7 in HCC, we utilized Wnt3 overexpressing FOCUS HCC cells (FOCUS-Wnt3) and human tumors. RESULTS: In hepatitis B virus (HBV)-induced HCC, Wnt3 was upregulated in tumor and peritumoral tissues compared to normal liver and downstream beta-catenin target genes were also increased in these samples. Activation of the Wnt/beta-catenin pathway in FOCUS-Wnt3 cells was demonstrated by beta-catenin accumulation, enhanced TCF transcriptional activity and proliferation rate. The activation of Wnt/beta-catenin signaling in FOCUS-Wnt3 was abolished by a knockdown of FZD7 expression by siRNA. More important, a specific Wnt3-FZD7 interaction was observed by co-immunoprecipitation experiments, which suggest that the action of Wnt3 was mediated via FZD7. CONCLUSIONS: These findings demonstrate a functional interaction between Wnt3 and FZD7 leading to activation of the Wnt/beta-catenin signaling pathway in HCC cells and may play a role during hepatocarcinogenesis.
BACKGROUND/AIMS: The canonical Wnt signaling is frequently activated in humanhepatocellular carcinoma (HCC). We previously demonstrated that upregulation of Frizzled-7 receptor (FZD7) in HCC was associated with nuclear accumulation of wild-type beta-catenin. Here, we investigated Wnt ligand(s) that may activate the Wnt/beta-catenin pathway through FZD7 in HCC cells. METHODS: To identify Wnt ligand expression, RT-PCR was performed in HCC cells. To evaluate the function of Wnt3 and FZD7 in HCC, we utilized Wnt3 overexpressing FOCUS HCC cells (FOCUS-Wnt3) and humantumors. RESULTS: In hepatitis B virus (HBV)-induced HCC, Wnt3 was upregulated in tumor and peritumoral tissues compared to normal liver and downstream beta-catenin target genes were also increased in these samples. Activation of the Wnt/beta-catenin pathway in FOCUS-Wnt3 cells was demonstrated by beta-catenin accumulation, enhanced TCF transcriptional activity and proliferation rate. The activation of Wnt/beta-catenin signaling in FOCUS-Wnt3 was abolished by a knockdown of FZD7 expression by siRNA. More important, a specific Wnt3-FZD7 interaction was observed by co-immunoprecipitation experiments, which suggest that the action of Wnt3 was mediated via FZD7. CONCLUSIONS: These findings demonstrate a functional interaction between Wnt3 and FZD7 leading to activation of the Wnt/beta-catenin signaling pathway in HCC cells and may play a role during hepatocarcinogenesis.
Authors: Alex Gregorieff; Daniel Pinto; Harry Begthel; Olivier Destrée; Menno Kielman; Hans Clevers Journal: Gastroenterology Date: 2005-08 Impact factor: 22.682
Authors: Philippe Merle; Miran Kim; Marc Herrmann; Anand Gupte; Lydie Lefrançois; Sophia Califano; Christian Trépo; Shinji Tanaka; Ludmila Vitvitski; Suzanne de la Monte; Jack R Wands Journal: J Hepatol Date: 2005-06-21 Impact factor: 25.083
Authors: Chandanamali Punchihewa; Antonio M Ferreira; Robert Cassell; Patrick Rodrigues; Naoaki Fujii Journal: Protein Sci Date: 2009-05 Impact factor: 6.725
Authors: Chelsea Q Xu; Suzanne M de la Monte; Ming Tong; Chiung-Kuei Huang; Miran Kim Journal: Alcohol Clin Exp Res Date: 2015-04-23 Impact factor: 3.455
Authors: Yoshito Tomimaru; Hironori Koga; Hirohisa Yano; Suzanne de la Monte; Jack R Wands; Miran Kim Journal: Liver Int Date: 2013-05-08 Impact factor: 5.828
Authors: Waihong Chung; Miran Kim; Suzanne de la Monte; Lisa Longato; Rolf Carlson; Betty L Slagle; Xiaoqun Dong; Jack R Wands Journal: Cancer Lett Date: 2015-10-01 Impact factor: 8.679